Abstract Objective: The goal of the paper is to determine inter-rater reliability of trained examiners performing standardized strength assessments using manual muscle testing (MMT). Design, subjects, and setting: The authors report on 19 trainees undergoing quality assurance within a multi-site prospective cohort study. Intervention: Inter-rater reliability for specially trained evaluators (''trainees'') and a reference rater, performing MMT using both simulated and actual patients recovering from critical illness was evaluated. Measurements and results: Across 26 muscle groups tested by 19 trainee-reference rater pairs, the median (interquartile range) percent agreement and intraclass correlation coefficient (ICC; 95% CI) were: 96% (91, 98%) and 0.98 (0.95, 1.00), respectively. Across all 19 pairs, the ICC (95% CI) for the overall composite MMT score was 0.99 (0.98-1.00). When limited to actual patients, the ICC was 1.00 (95% CI 0.99-1.00). The agreement (kappa; 95% CI) in detecting clinically significant weakness was 0.88 (0.44-1.00). Conclusions: MMT has excellent inter-rater reliability in trained examiners and is a reliable method of comprehensively assessing muscle strength.
Introduction
There is growing awareness of persistent neuromuscular complications after critical illness [1] [2] [3] [4] [5] . In studies evaluating interventions for improving muscle weakness, the reliable assessment of strength is key [6] [7] [8] . Standardized physical examination using manual muscle testing (MMT) is a widely accepted method for evaluating strength [9, 10] .
Prior studies evaluating the reproducibility of MMT have focused on a limited number of muscles or specific patient populations [11] [12] [13] [14] . There is little data on the reliability of comprehensive MMT assessments in ICU survivors. Our objective is to determine the inter-rater reliability of trained examiners performing comprehensive MMT assessments using both actual patients recovering from critical illness and simulated patients.
Methods
In an ongoing study [15] approved by the Institutional Review Board of Johns Hopkins University, both clinicians and research assistants were trained to perform MMT with reproducibility evaluated against a single reference rater.
Manual muscle strength testing MMT was scored using the 6-point Medical Research Council (MRC) scale [10] . Strength was evaluated bilaterally for 6 upper-and 7 lower-extremity muscle groups (total of 26 groups).
MRC scores for the 26 muscle groups were summed to yield a composite score of overall strength (range 0-130), as done previously [3, 9, 14] . Composite scores were also separately calculated for the upper (0-60) and lower extremities (0-70). Finally, an abbreviated composite score (0-60) was calculated based on a subset of 3 upper and 3 lower muscle groups, for comparison with a prior landmark study [9] . Composite scores were also dichotomized to designate patients with ''clinically significant muscle weakness'' if their score was \80% of the maximum score (i.e. average MRC score of \4 of 5 in all muscle groups) [3, 4, 9, 14] .
All personnel performing MMT completed multistep training prior to their reliability assessments, including: review of a photo-illustrated MMT instruction manual; didactic teaching; and supervised practice by a trained staff member. The sole reference rater (NDC) was a physiotherapist with [30 years experience in both teaching and performing MMT across both clinical and research settings, particularly for ICU patients.
Nineteen different trainees underwent single-blinded MMT reliability evaluations with the reference rater. The trainees had various professional backgrounds (range of relevant experience with MMT): five physicians (1-10 years), four nurses (none), two respiratory therapists (none), five physiotherapists (6 months-5 years), one pharmacist (none), and two research assistants (none). Evaluations were conducted in a clinic setting using either an actual research participant (9 of 19) or a simulated patient (10 of 19) who effectively simulated a wide range of strength following training by the reference rater.
Statistical methods
For each of the 26 individual muscle groups, a median MMT score was separately calculated for the trainees versus reference rater and compared using the Wilcoxon signed rank test. For each trainee-reference rater pair, the overall composite score, upper and lower extremity composite scores, and the abbreviated composite score, were compared using percent agreement and intra-class correlation coefficients (ICC). Percent agreement was calculated by computing the number of individual muscle groups with exact agreement divided by the total number of muscles groups evaluated. To understand the direction of trainees' bias in disagreements among the pairs, we calculated a ''proportion of lower disagreement'' representing the proportion of all disagreements in which the trainee gave a lower score than reference rater. Using the nomenclature of Shrout and Fleiss [16] , an ICC (2,1) was calculated to provide a measure of inter-rater reliability that could be generalized beyond the study.
Reproducibility across all trainee-reference rater pairs was also determined using ICC for the overall and abbreviated composite scores. A kappa statistic was used to determine agreement in detecting the binary outcome of clinically significant muscle weakness. Statistical analyses were performed with Stata v.10.1 (College Station, TX, USA). Table 1 describes the range and median MMT score for each of the 26 muscle groups. Across these muscle groups, there were no statistically significant or clinically important differences in mean MMT score between the 19 pairs. Table 2 describes the reproducibility of the composite scores for each of the 19 pairs. For all 26 muscles, the median (interquartile range) values for the percent agreement and ICC were: 96% (91, 98%) and 0.98 (0.95, 1.00). The median proportion of lower disagreement was 0% (0, 10%) indicating that trainees were biased toward higher strength scores versus reference rater. For the upper extremity, the median values for percent agreement and ICC were: 92% (87, 100%) and 0.99 (0.93, 1.00). The median proportion of lower disagreement was 0% (0, 10%). For the lower extremity, the median values for percent agreement and ICC were: 100% (93, 100%) and 1.00 (0.98, 1.00). The median proportion of lower disagreement was 0% (0, 0%).
Results
For the median (interquartile range) overall composite MMT score, there was no clinically or statistically significant difference between trainees versus reference rater [96 (85-109) vs. 98 (83-107), P = 0.052]. Across all 19 trainee-reference rater pairs, the ICC (95% CI) for the overall, abbreviated, upper extremity, and lower extremity composite scores were: 0.99 (0.98-1.00), 0.99 (0.97-1.00), 0.97 (0.94-0.99), and 0.99 (0.98-1.00), respectively. When this analysis was restricted to the subgroup of assessments performed on the research participants, the ICC (95% CI) for the overall composite score was 1.00 (0.99-1.00), consistent with the overall analysis.
The kappa (95% CI) for agreement in detecting clinically significant weakness for all muscle groups, the upper extremities only, and the lower extremities only was 0.88 (0.44-1.00), 0.88 (0.44-1.00), and 1.00 (0.55-1.00), respectively. Analysis using the abbreviated composite score demonstrated a kappa (95% CI) of 1.00 (0.55-1.00).
Discussion
There is excellent reproducibility for MMT assessments across a wide range of specially trained research personnel who perform these evaluations. For the 26 muscle groups evaluated, MMT has substantial reproducibility with a median percent agreement and ICC of 96% and 0.98, respectively. Furthermore, ICC (95% CI) for both the overall and abbreviated composite scores across all trainee-reference rater pairs was high at 0.99 (0.98-1.00) and 0.99 (0.97-1.00), respectively. These results were consistent when the analysis was limited to evaluations performed using only research participants (i.e. excluding simulated patients). Finally, there was substantial agreement between the trainees and reference rater for detecting clinically significant weakness using both overall and abbreviated composite scores.
Our study evaluates the reproducibility of a comprehensive MMT assessment in ICU survivors, who often experience long-term muscle weakness [1, 2] . Our results are consistent with prior studies, evaluating other patient populations, that showed excellent percent agreement (range 82-98%) in composite MMT scores between raters [11, 17] . Our findings were also similar to two studies of MMT in muscular dystrophy patients (ICC 0.75-0.96) [18, 19] . Finally, our findings are consistent with a prior study [14] in Guillain-Barre patients, which reported an ICC of 0.96 for the abbreviated composite score. Our study is unique in evaluating the reproducibility of a comprehensive MMT examination, involving 26 muscle Number assessed Table 2 Inter-rater reliability for individual MMT scores across 19 evaluations Proportion of lower disagreement when trainee score is less than the gold standard scores groups, within a study of ICU survivors. However, we are not specifically advocating for the evaluation of 26 muscle groups and the introduction of a new threshold (i.e. \104 out of 130), given the excellent inter-rater reliability demonstrated by the abbreviated composite score. When MMT scores differed between trainees versus reference rater, the direction of bias was towards an overestimation of strength. This conservative bias indicates that trainees do not appear to overestimate weakness. Furthermore, despite variability in reliability across all trainee-reference rater pairs in composite scores, the ability to detect clinically significant weakness demonstrated substantial reliability.
The MMT training program in this study likely played an important role in these findings, consistent with prior studies which suggested that greater training and clinical experience improved MMT reliability [13, 20] .
ICU patients often experience prolonged immobility leading to substantial generalized weakness [2, 5, 9] . Therefore, a global measure of strength (e.g. composite MMT score) is important in gauging the severity of this weakness, and the impact of therapeutic interventions. In addition, the ability to ascertain muscle strength separately in upper and lower extremities may be helpful in prognosticating a patient's ability to perform specific functional tasks (e.g. ambulation, eating).
Our study has potential limitations. Approximately half of the study population were simulated patients. This study design may affect the generalizability of our findings; however, analysis of the subgroup of actual participants was consistent with the overall analysis. Furthermore, use of specially trained simulated patients allowed us to mimic a wide range of muscle weakness for comprehensive quality assurance testing versus use of real participants who may have less variability in strength across muscle groups and fatigue with repeated testing by both the trainee and reference rater. Finally, using an MRC score of \80% to define clinically significant weakness is arbitrary, as there has been limited research evaluating MMT scores and functional abilities. However, this methodology has been widely employed [3, 4, 9, 14] , making this threshold important for comparisons across studies.
In conclusion, MMT has excellent reproducibility when performed by both clinicians and research assistants who received specific training for research purposes. A composite score, combining MMT assessments from the upper and lower extremities, had high reproducibility for detecting clinically significant weakness. Among trained research staff, MMT is reliable for longitudinal and comprehensive assessment of strength.
